CompaniesPepscan Therapeutics

Pepscan Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

12

By Phase

PHASE1/PHASE2: 1

By Status

UNKNOWN: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00895466
Hover over trial bars to see details

Recent Trials

NCT00895466Lead Sponsor
Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
PHASE1/PHASE2Unknown
12 participants
Started: Oct 31, 2008